Beyond chemotherapy: targeted therapies in ovarian cancer - PubMed (original) (raw)

Review

doi: 10.1038/nrc2583.

Affiliations

Review

Beyond chemotherapy: targeted therapies in ovarian cancer

Timothy A Yap et al. Nat Rev Cancer. 2009 Mar.

Abstract

Ovarian cancer is the leading cause of death from gynaecological malignancies in the Western world. Despite the evolution of surgical techniques and meticulously designed chemotherapy regimens, relapse remains almost inevitable in patients with advanced disease. In an age when great advances have been made in understanding the genetics and molecular biology of this heterogeneous disease, it is likely that the introduction of novel targeted therapies will have a major impact on the management of ovarian cancer. Importantly, such strategies might allow selection of treatments based on the molecular characteristics of tumours and bring us closer to an era of personalized medicine.

Trial registration: ClinicalTrials.gov NCT00429793 NCT00523432 NCT00610714 NCT00628251 NCT00753545.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Gynecol Oncol. 1991 Jul;42(1):3-8 - PubMed
    1. Clin Cancer Res. 2005 Aug 1;11(15):5539-48 - PubMed
    1. Cancer. 2002 Feb 1;94(3):707-12 - PubMed
    1. Gynecol Oncol. 1993 Jul;50(1):78-83 - PubMed
    1. Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11154-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources